Liverome: A curated database of liver cancer-related gene signatures with self-contained context information

10th Int. Conference on Bioinformatics - 1st ISCB Asia Joint Conference 2011, InCoB 2011/ISCB-Asia 2011: Computational Biology - Proceedings from Asia Pacific Bioinformatics Network (APBioNet)

Volumn 12, Issue SUPPL. 3, 2011, Pages

  Lee, Langho ^a   Wang, Kai ^b   Li, Gang ^b   Xie, Zhi ^b   Wang, Yuli ^b   Xu, Jiangchun ^b   Sun, Shaoxian ^b   Pocalyko, David ^b   Bhak, Jong ^c   Kim, Chulhong ^c   Lee, Kee Ho ^d   Jang, Ye Jin ^a   Yeom, Young Il ^a   Yoo, Hyang Sook ^a   Hwang, Seungwoo ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c Theragen BiO Institute   (South Korea)

^d Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL INSIGHT; BIOLOGICAL INTERPRETATION; CANDIDATE GENES; CONTEXT INFORMATION; CURATION; DATA COVERAGE; DATABASE CONTENTS; DIFFERENTIAL EXPRESSIONS; GUIDED BROWSING; HEPATOCELLULAR CARCINOMA; LIVER CANCERS; MOLECULAR PROFILING; PRIORITIZATION; PROTEIN EXPRESSIONS; SIGNATURE DATABASE; WEB INTERFACE;

BIOINFORMATICS; DATABASE SYSTEMS; DISEASES; QUERY PROCESSING; SEMANTICS;

GENE EXPRESSION;

TRANSCRIPTOME;

ARTICLE; COMPUTER INTERFACE; FACTUAL DATABASE; GENETICS; HUMAN; INFORMATION RETRIEVAL; INTERNET; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM;

CARCINOMA, HEPATOCELLULAR; DATABASES, FACTUAL; HUMANS; INFORMATION STORAGE AND RETRIEVAL; INTERNET; LIVER NEOPLASMS; TRANSCRIPTOME; USER-COMPUTER INTERFACE;

EID: 84862250159     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1186/1471-2164-12-S3-S3     Document Type: Conference Paper

References (25)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Bruix J, Sherman M: Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
3. Dietmann S, Lee W, Wong P, Rodchenkov I, Antonov AV: CCancer: a bird's eye view on gene lists reported in cancer-related studies. Nucleic Acids Res 2010, 38:W118-W123.
4. Li H, He Y, Ding G, Wang C, Xie L, Li Y: dbDEPC: a database of differentially expressed proteins in human cancers. Nucleic Acids Res 2010, 38:D658-D664.
5. Hsu CN, Lai JM, Liu CH, Tseng HH, Lin CY, Lin KT, Yeh HH, Sung TY, Hsu WL, Su LJ, Lee SA, Chen CH, Lee GC, Lee DT, Shiue YL, Yeh CW, Chang CH, Kao CY, Huang CY: Detection of the inferred interaction network in hepatocellular carcinoma from EHCO (Encyclopedia of Hepatocellular Carcinoma genes Online). BMC Bioinformatics 2007, 8:66.
6. Culhane AC, Schwarzl T, Sultana R, Picard KC, Picard SC, Lu TH, Franklin KR, French SJ, Papenhausen G, Correll M, Quackenbush J: GeneSigDB-a curated database of gene expression signatures. Nucleic Acids Res 2010, 38:D716-D725.
7. Chandran UR, Dhir R, Ma C, Michalopoulos G, Becich M, Gilbertson J: Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors. BMC Cancer 2005, 5:45.
8. Jeong SK, Kwon MS, Lee EY, Lee HJ, Cho SY, Kim H, Yoo JS, Omenn GS, Aebersold R, Hanash S, Paik YK: BiomarkerDigger: a versatile disease proteome database and analysis platform for the identification of plasma cancer biomarkers. Proteomics 2009, 9:3729-3740.
9. Hsu HC, Cheng W, Lai PL: Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution. Cancer Res 1997, 57:5179-5184.
10. Midorikawa Y, Ishikawa S, Iwanari H, Imamura T, Sakamoto H, Miyazono K, Kodama T, Makuuchi M, Aburatani H: Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int J Cancer 2003, 103:455-465.
11. Yamauchi N, Watanabe A, Hishinuma M, Ohashi K, Midorikawa Y, Morishita Y, Niki T, Shibahara J, Mori M, Makuuchi M, Hippo Y, Kodama T, Iwanari H, Aburatani H, Fukayama M: The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. Mod Pathol 2005, 18:1591-1598.
12. Pogribny IP, James SJ, Jernigan S, Pogribna M: Genomic hypomethylation is specific for preneoplastic liver in folate/methyl deficient rats and does not occur in non-target tissues. Mutat Res 2004, 548:53-59.
13. Ghoshal K, Li X, Datta J, Bai S, Pogribny I, Pogribny M, Huang Y, Young D, Jacob ST: A folate- and methyl-deficient diet alters the expression of DNA methyltransferases and methyl CpG binding proteins involved in epigenetic gene silencing in livers of F344 rats. J Nutr 2006, 136:1522-1527.
14. Szyf M: Therapeutic implications of DNA methylation. Future Oncol 2005, 1:125-135.
15. Pascale RM, Simile MM, Satta G, Seddaiu MA, Daino L, Pinna G, Vinci MA, Gaspa L, Feo F: Comparative effects of L-methionine, S-adenosyl-Lmethionine and 5'-methylthioadenosine on the growth of preneoplastic lesions and DNA methylation in rat liver during the early stages of hepatocarcinogenesis. Anticancer Res 1991, 11:1617-1624.
16. Forbes SA, Tang G, Bindal N, Bamford S, Dawson E, Cole C, Kok CY, Jia M, Ewing R, Menzies A, Teague JW, Stratton MR, Futreal PA: COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res 2010, 38: D652-D657.
17. Migita T, Narita T, Nomura K, Miyagi E, Inazuka F, Matsuura M, Ushijima M, Mashima T, Seimiya H, Satoh Y, Okumura S, Nakagawa K, Ishikawa Y: ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. Cancer Res 2008, 68:8547-8554.
18. Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D, Hingorani SR, Tuveson DA, Thompson CB: ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 2005, 8:311-321.
19. Furge KA, Dykema KJ, Ho C, Chen X: Comparison of array-based comparative genomic hybridization with gene expression-based regional expression biases to identify genetic abnormalities in hepatocellular carcinoma. BMC Genomics 2005, 6:67.
20. Amann T, Hellerbrand C: GLUT1 as a therapeutic target in hepatocellular carcinoma. Expert Opin Ther Targets 2009, 13:1411-1427.
21. Langfelder P, Horvath S: WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008, 9:559.
22. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005, 102:15545-15550.
23. Daskalow K, Pfander D, Weichert W, Rohwer N, Thelen A, Neuhaus P, Jonas S, Wiedenmann B, Benckert C, Cramer T: Distinct temporospatial expression patterns of glycolysis-related proteins in human hepatocellular carcinoma. Histochem Cell Biol 2009, 132:21-31.
24. Xu RH, Pelicano H, Zhou Y, Carew JS, Feng L, Bhalla KN, Keating MJ, Huang P: Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res 2005, 65:613-621.
25. Lamb JR, Zhang C, Xie T, Wang K, Zhang B, Hao K, Chudin E, Fraser HB, Millstein J, Ferguson M, Suver C, Ivanovska I, Scott M, Philippar U, Bansal D, Zhang Z, Burchard J, Smith R, Greenawalt D, Cleary M, Derry J, Loboda A, Watters J, Poon RTP, Fan ST, Yeung C, Lee NPY, Guinney J, Molony C, Emilsson V, Buser-Doepner C, Zhu J, Friend S, Mao M, Shaw PM, Dai H, Luk JM, Schadt EE: Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting. PLoS ONE 2011, 6:e20090.